Current and emerging trends in prostate cancer immunotherapy

Bibliographic Details
Main Authors: Adam Schatz, Badar M Mian
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Asian Journal of Andrology
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2019;volume=21;issue=1;spage=6;epage=11;aulast=Schatz
_version_ 1819014972407021568
author Adam Schatz
Badar M Mian
author_facet Adam Schatz
Badar M Mian
author_sort Adam Schatz
collection DOAJ
first_indexed 2024-12-21T02:24:20Z
format Article
id doaj.art-be4d41486cd844e78cacc03064ddb4c0
institution Directory Open Access Journal
issn 1008-682X
1745-7262
language English
last_indexed 2024-12-21T02:24:20Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Andrology
spelling doaj.art-be4d41486cd844e78cacc03064ddb4c02022-12-21T19:19:03ZengWolters Kluwer Medknow PublicationsAsian Journal of Andrology1008-682X1745-72622019-01-0121161110.4103/aja.aja_52_17Current and emerging trends in prostate cancer immunotherapyAdam SchatzBadar M Mianhttp://www.ajandrology.com/article.asp?issn=1008-682X;year=2019;volume=21;issue=1;spage=6;epage=11;aulast=Schatz
spellingShingle Adam Schatz
Badar M Mian
Current and emerging trends in prostate cancer immunotherapy
Asian Journal of Andrology
title Current and emerging trends in prostate cancer immunotherapy
title_full Current and emerging trends in prostate cancer immunotherapy
title_fullStr Current and emerging trends in prostate cancer immunotherapy
title_full_unstemmed Current and emerging trends in prostate cancer immunotherapy
title_short Current and emerging trends in prostate cancer immunotherapy
title_sort current and emerging trends in prostate cancer immunotherapy
url http://www.ajandrology.com/article.asp?issn=1008-682X;year=2019;volume=21;issue=1;spage=6;epage=11;aulast=Schatz
work_keys_str_mv AT adamschatz currentandemergingtrendsinprostatecancerimmunotherapy
AT badarmmian currentandemergingtrendsinprostatecancerimmunotherapy